Schizophrenia Research Review Issue 51
In this issue:
Clozapine vs. amisulpride vs. olanzapine after treatment failure in first-episode psychosis
‘Dementia’ characteristics in severe treatment-resistant schizophrenia
Basmisanil in cognitive impairment associated with schizophrenia
Dantrolene in neuroleptic malignant syndrome
Readmission with 1- vs. 2-monthly aripiprazole LAI
Antipsychotic discontinuation vs. maintenance in first-episode non-affective psychosis
Adversity in childhood & psychosis
Community-based schizophrenia rehabilitation in China
Portrayals of schizophrenia in news media
Community initiation of clozapine among young Australians
Expert contributor
Professor Dan Siskind
Professor Siskind trained as a psychiatrist in Australia and the United States. He works clinically as a psychiatrist in Brisbane, Australia with people with treatment-refractory schizophrenia. His research interests include treatment-refractory schizophrenia, clozapine and the physical health comorbidities associated with schizophrenia. He has over 300 publications and AU$60million in competitive research grants, with over AU$7 […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.